{"transactions":[{"id":799937,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Interim CFO"}}],"security":"COMMON STOCK","published_at":"2026-04-27T20:05:20.000Z","date":"2026-04-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":19,"price":0.75,"value":14.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"19 shares of common stock were relinquished to cover tax liability associated with the delivery of shares of common stock upon the vesting of restricted stock units."}],"balance_after":1615,"source":{"system":"sec-edgar","filing":"0001104659-26-049430","document":"tm2612756-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000110465926049430/tm2612756-1_4seq1.xml","form_type":"4"}},{"id":1164747,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Interim CFO"}}],"security":"COMMON STOCK","published_at":"2025-04-28T20:30:13.000Z","date":"2025-04-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":27,"price":1.24,"value":33.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"27 shares of common stock were relinquished to cover tax liability associated with the delivery of shares of common stock upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective January 15, 2025, the Issuer effected a one-for-fifty reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split."}],"balance_after":1634,"source":{"system":"sec-edgar","filing":"0001104659-25-040237","document":"tm2513385-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000110465925040237/tm2513385-1_4seq1.xml","form_type":"4"}},{"id":1491332,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-06-05T00:35:40.000Z","date":"2024-05-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1396,"price":0.35,"value":488.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"1,396 shares of common stock were relinquished to cover tax liability associated with the delivery of shares of common stock upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,000 shares of common stock acquired under the Mustang Bio, Inc. Employee Stock Purchase Plan on March 1, 2024."}],"balance_after":83024,"source":{"system":"sec-edgar","filing":"0001104659-24-068411","document":"tm2416466-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000110465924068411/tm2416466-2_4seq1.xml","form_type":"4"}},{"id":1491331,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-06-05T00:33:33.000Z","date":"2023-04-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1572,"price":4.21,"value":6618.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"1,572 shares of common stock were relinquished to cover tax liability associated with the delivery of shares of common stock upon the vesting of restricted stock units."}],"balance_after":79420,"source":{"system":"sec-edgar","filing":"0001104659-24-068409","document":"tm2416466-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000110465924068409/tm2416466-1_4seq1.xml","form_type":"4"}},{"id":1491330,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-06-05T00:33:33.000Z","date":"2022-04-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1248,"price":12.15,"value":15163.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"1,248 shares of common stock were relinquished to cover tax liability associated with the delivery of shares of common stock upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount of common stock reflected on this Form 4 has been adjusted to reflect a 1-for-15 reverse stock split that occurred subsequent to this transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 3,975 shares of common stock acquired under the Mustang Bio, Inc. Employee Stock Purchase Plan on March 1, 2023 and September 1, 2023."}],"balance_after":80992,"source":{"system":"sec-edgar","filing":"0001104659-24-068409","document":"tm2416466-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000110465924068409/tm2416466-1_4seq1.xml","form_type":"4"}},{"id":1832646,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"COMMON STOCK, PAR VALUE $0.0001","published_at":"2023-07-07T20:06:00.000Z","date":"2023-04-24","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of 5,000 restricted stock units that will vest in four annual installments after the grant date, vesting in full on April 24, 2027."},{"field":"shares","element":"transactionShares","label":"F2","text":"Effective April 3, 2023, the Issuer effected a fifteen-for-one reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective April 3, 2023, the Issuer effected a fifteen-for-one reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":111079,"source":{"system":"sec-edgar","filing":"0001104659-23-079110","document":"tm2320790-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000110465923079110/tm2320790-1_4seq1.xml","form_type":"4"}},{"id":1931780,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.0001","published_at":"2023-04-03T20:51:42.000Z","date":"2022-09-13","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.5164,"value":2582.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired as purchases made under the Issuer's Employee Stock Purchase Plan (\"ESPP\") during the ESPP offering period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":1098987,"source":{"system":"sec-edgar","filing":"0001104659-23-040934","document":"tm2311237d6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000110465923040934/tm2311237d6_4seq1.xml","form_type":"4"}},{"id":1931779,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.0001","published_at":"2023-04-03T20:51:42.000Z","date":"2022-06-21","kind":"grant","planned":false,"acquired":true,"shares":61000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents an award of 61,000 restricted stock units that will vest in four annual installments after the grant date, vesting in full on April 24, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":1093987,"source":{"system":"sec-edgar","filing":"0001104659-23-040934","document":"tm2311237d6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000110465923040934/tm2311237d6_4seq1.xml","form_type":"4"}},{"id":1931778,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.0001","published_at":"2023-04-03T20:51:42.000Z","date":"2022-03-18","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.739,"value":3695.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired as purchases made under the Issuer's Employee Stock Purchase Plan (\"ESPP\") during the ESPP offering period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":1032987,"source":{"system":"sec-edgar","filing":"0001104659-23-040934","document":"tm2311237d6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000110465923040934/tm2311237d6_4seq1.xml","form_type":"4"}},{"id":2521012,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"COMMON STOCK","published_at":"2021-11-08T21:35:49.000Z","date":"2021-10-27","kind":"purchase","acquired":true,"shares":65000,"price":2.24,"value":145600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the purchase transactions on October 27, 2021, was $2.22 to $2.26. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a shareholder of the Issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":1027987,"source":{"system":"sec-edgar","filing":"0001104659-21-135706","document":"tm2132286-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000110465921135706/tm2132286-1_4seq1.xml","form_type":"4"}},{"id":2559507,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"COMMON STOCK","published_at":"2021-09-24T21:23:31.000Z","date":"2021-08-31","kind":"grant","acquired":true,"shares":2746,"price":2.58,"value":7084.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Mustang Bio, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on March 1, 2021 and ending on August 31, 2021 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's ordinary shares on August 31, 2021 (the purchase date of the offering period)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":962987,"source":{"system":"sec-edgar","filing":"0001104659-21-119384","document":"tm2128458-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000110465921119384/tm2128458-1_4seq1.xml","form_type":"4"}},{"id":2612485,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"COMMON STOCK","published_at":"2021-08-05T20:23:57.000Z","date":"2021-07-30","kind":"purchase","acquired":true,"shares":86206,"price":2.91,"value":250859.46,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the purchase transactions on July 30, 2021, was $2.89 to $2.94. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a shareholder of the Issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":960241,"source":{"system":"sec-edgar","filing":"0001104659-21-100783","document":"tm2124277-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000110465921100783/tm2124277-1_4seq1.xml","form_type":"4"}},{"id":2637703,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"COMMON STOCK","published_at":"2021-07-08T20:31:51.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":61000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Common Stock of Mustang Bio, Inc. The restricted stock units will vest at different times over a period of 4 years."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":874035,"source":{"system":"sec-edgar","filing":"0001104659-21-090242","document":"tm2121675-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000110465921090242/tm2121675-3_4seq1.xml","form_type":"4"}},{"id":2735459,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"COMMON STOCK","published_at":"2021-04-29T20:31:40.000Z","date":"2020-05-22","kind":"sale","acquired":false,"shares":8348,"price":3.04,"value":25377.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"8,348 shares were sold in connection with the vesting of 30,500 shares on April 24, 2020, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Litchman's tax withholding obligations. Mr. Litchman had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":813035,"source":{"system":"sec-edgar","filing":"0001104659-21-057674","document":"tm2113475d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000110465921057674/tm2113475d1_4.xml","form_type":"4"}},{"id":2735458,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"COMMON STOCK","published_at":"2021-04-29T20:31:40.000Z","date":"2020-05-22","kind":"sale","acquired":false,"shares":4025,"price":3.04,"value":12236.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"4,025 shares were sold in connection with the vesting of 15,250 shares on March 26, 2020, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Litchman's tax withholding obligations. Mr. Litchman had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":821383,"source":{"system":"sec-edgar","filing":"0001104659-21-057674","document":"tm2113475d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000110465921057674/tm2113475d1_4.xml","form_type":"4"}},{"id":2788657,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"COMMON STOCK","published_at":"2021-03-15T10:35:12.000Z","date":"2021-03-05","kind":"purchase","acquired":true,"shares":165562,"price":3.12,"value":516553.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the purchase transactions on March 5, 2021, was $3.01 to $3.177. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a shareholder of the Issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":825408,"source":{"system":"sec-edgar","filing":"0001104659-21-035857","document":"tm219639d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000110465921035857/tm219639d1_4seq1.xml","form_type":"4"}},{"id":2788656,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"COMMON STOCK","published_at":"2021-03-15T10:35:12.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":5000,"price":2.83,"value":14150.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Mustang Bio, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on September 1, 2020 and ending on February 28, 2021 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's ordinary shares on September 1, 2020 (the purchase date of the offering period)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":659846,"source":{"system":"sec-edgar","filing":"0001104659-21-035857","document":"tm219639d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000110465921035857/tm219639d1_4seq1.xml","form_type":"4"}},{"id":2934107,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"COMMON STOCK","published_at":"2020-12-22T21:18:10.000Z","date":"2020-12-15","kind":"purchase","acquired":true,"shares":100000,"price":2.91,"value":291000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the purchase transactions on December 15, 2020, was $2.85 to $2.98. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a shareholder of the Issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":654846,"source":{"system":"sec-edgar","filing":"0001104659-20-138581","document":"tm2039180-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000110465920138581/tm2039180-1_4.xml","form_type":"4"}},{"id":2934106,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"COMMON STOCK","published_at":"2020-12-22T21:18:10.000Z","date":"2020-09-15","kind":"grant","acquired":true,"shares":61000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"61,000 shares are restricted share units which vest over various time periods."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":554846,"source":{"system":"sec-edgar","filing":"0001104659-20-138581","document":"tm2039180-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000110465920138581/tm2039180-1_4.xml","form_type":"4"}},{"id":2934105,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"COMMON STOCK","published_at":"2020-12-22T21:18:10.000Z","date":"2020-08-31","kind":"grant","acquired":true,"shares":5000,"price":2.48,"value":12400.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Mustang Bio, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on March 1, 2020 and ending on August 31, 2020 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's ordinary shares on February 28, 2020 (the purchase date of the offering period)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":493846,"source":{"system":"sec-edgar","filing":"0001104659-20-138581","document":"tm2039180-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000110465920138581/tm2039180-1_4.xml","form_type":"4"}},{"id":3110048,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"COMMON STOCK","published_at":"2020-06-15T20:32:15.000Z","date":"2020-06-11","kind":"purchase","acquired":true,"shares":153846,"price":3.25,"value":499999.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":488846,"source":{"system":"sec-edgar","filing":"0001104659-20-073411","document":"tm2022538-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000110465920073411/tm2022538-1_4.xml","form_type":"4"}},{"id":3136449,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-05-22T23:07:21.000Z","date":"2020-05-21","kind":"purchase","acquired":true,"shares":90000,"price":3.13,"value":281700.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":335000,"source":{"system":"sec-edgar","filing":"0001104659-20-065513","document":"tm2020825d1_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000110465920065513/tm2020825d1_form4.xml","form_type":"4"}},{"id":3136448,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-05-22T23:07:21.000Z","date":"2020-05-14","kind":"purchase","acquired":true,"shares":90000,"price":2.79,"value":251100.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":245000,"source":{"system":"sec-edgar","filing":"0001104659-20-065513","document":"tm2020825d1_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000110465920065513/tm2020825d1_form4.xml","form_type":"4"}},{"id":3167164,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-04-29T12:48:47.000Z","date":"2020-03-26","kind":"grant","acquired":true,"shares":122000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Common Stock of Mustang Bio, Inc."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":155000,"source":{"system":"sec-edgar","filing":"0001104659-20-052884","document":"tm2018004-2_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000110465920052884/tm2018004-2_form4.xml","form_type":"4"}},{"id":3167163,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-04-29T12:48:47.000Z","date":"2020-03-05","kind":"grant","acquired":true,"shares":5000,"price":2.48,"value":12400.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Mustang Bio, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on September 1, 2019 and ending on February 29, 2020 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's ordinary shares on February 28, 2020 (the last trading day of the offering period)."}],"balance_after":33000,"source":{"system":"sec-edgar","filing":"0001104659-20-052884","document":"tm2018004-2_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000110465920052884/tm2018004-2_form4.xml","form_type":"4"}},{"id":3726124,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-12-18T21:59:49.000Z","date":"2018-12-10","kind":"purchase","acquired":true,"shares":8000,"price":3.3506,"value":26804.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on November 20, 2018 was $3.8751 to $3.8951, the range of prices for the purchase transactions on November 21, 2018 was $4.1992 to $4.219, the range of prices for the purchase transactions on November 26, 2018 was $3.8696 to $3.8708 and the range of prices for the purchase transactions on December 10, 2018 was $ 3.34 to $ 3.3532. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":28000,"source":{"system":"sec-edgar","filing":"0001144204-18-065170","document":"tv509180_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000114420418065170/tv509180_form4.xml","form_type":"4"}},{"id":3726123,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-12-18T21:59:49.000Z","date":"2018-12-04","kind":"purchase","acquired":true,"shares":7500,"price":3.6,"value":27000.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001144204-18-065170","document":"tv509180_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000114420418065170/tv509180_form4.xml","form_type":"4"}},{"id":3726122,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-12-18T21:59:49.000Z","date":"2018-11-26","kind":"purchase","acquired":true,"shares":5000,"price":3.8707,"value":19353.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on November 20, 2018 was $3.8751 to $3.8951, the range of prices for the purchase transactions on November 21, 2018 was $4.1992 to $4.219, the range of prices for the purchase transactions on November 26, 2018 was $3.8696 to $3.8708 and the range of prices for the purchase transactions on December 10, 2018 was $ 3.34 to $ 3.3532. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001144204-18-065170","document":"tv509180_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000114420418065170/tv509180_form4.xml","form_type":"4"}},{"id":3726121,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-12-18T21:59:49.000Z","date":"2018-11-21","kind":"purchase","acquired":true,"shares":5000,"price":4.2096,"value":21048.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on November 20, 2018 was $3.8751 to $3.8951, the range of prices for the purchase transactions on November 21, 2018 was $4.1992 to $4.219, the range of prices for the purchase transactions on November 26, 2018 was $3.8696 to $3.8708 and the range of prices for the purchase transactions on December 10, 2018 was $ 3.34 to $ 3.3532. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001144204-18-065170","document":"tv509180_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000114420418065170/tv509180_form4.xml","form_type":"4"}},{"id":3726120,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":51147,"kind":"person","name":"Litchman Manuel MD","position":1,"cik":"0001709485","reported_name":"Litchman Manuel MD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-12-18T21:59:49.000Z","date":"2018-11-20","kind":"purchase","acquired":true,"shares":2500,"price":3.8881,"value":9720.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on November 20, 2018 was $3.8751 to $3.8951, the range of prices for the purchase transactions on November 21, 2018 was $4.1992 to $4.219, the range of prices for the purchase transactions on November 26, 2018 was $3.8696 to $3.8708 and the range of prices for the purchase transactions on December 10, 2018 was $ 3.34 to $ 3.3532. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001144204-18-065170","document":"tv509180_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1680048/000114420418065170/tv509180_form4.xml","form_type":"4"}}]}